New andropause screening panel released.(NEWS / NOUVELLES)(Brief article)

A new test panel called Androtest has been released by Opmedic Group, a healthcare-related services company based in Quebec. The Androtest is a complete screening profile used to diagnose and manage andropause, an age-related condition that affects men over 45 years of age due to a decline in testosterone levels.

The panel, developed through Opmedic's PROCREA Cliniques Division, includes an extended panel of biochemical markers and a detailed follow-up report that will help physicians diagnose a patient's andropause.

While a decrease in sex drive is often the main reason for a medical consultation by men, recent studies show that hormonal imbalances caused by andropause increase a man's risk of coronary artery disease, depression, lack of energy and mental acuity, a decrease in bone mass and an increase in abdominal fat.

Other symptoms associated with andropause include one or more of the following:

* Hot flashes and excessive sweating without physical activity;

* Loss of muscle and bone mass and strength;

* Lack of energy with diminished physical activity;

* Joint and muscle pain;

* Abdominal obesity;

* Sadness, irritability, and overall lack of interest;

* Depression;

* Sleep problems;

* Decline in mental acuity, concentration and short term memory;

* Loss of sex drive, leading to a decrease in performance and sexual activities;

Opmedic Group

Print Get the Mag Weekly Updates